OncoFrontier·Oct 26ESMO 2026: Blood Tests That Track Cancer Response Early, and What They Do Not Yet ProveEarly ctDNA results from ESMO 2026 show a blood test can track response, but it is not yet proven to guide treatment.
Adam Blum·Feb 11ctDNA Trials in Breast Cancer: How TREAT ctDNA, DARE and Apollo Are Changing Early InterventionAnd Why CancerBot’s Precision Trial Matching Is Becoming Even More Important Than Ever
PHG Foundation·Apr 4, 2023Liquid biopsies in cancerThe following is tidied up transcript from the Making science work for health podcast, produced by the PHG Foundation. This episode was…
Anchor Molecular·Sep 11, 2018Characterization of DNA-free Plasma and Its Usage as True Plasma-Based Quality Control Standards…Yabin Lu, Dan Luo, Alina Polonskaia, Anchor Molecular Inc. 7026 Koll Center Parkway, Suite 215, Pleasanton, CA 94566, U.S.A
ICR·Aug 12, 2016Using the seeds of cancer to guide treatment strategiesIn 1869, pathologist Thomas Ashworth noticed some unusual cells in the blood of a patient who had died of cancer. The cells didn’t look…
